NeoDynamics establishes reference centres in Germany to support the introduction of its novel pulse biopsy system NeoNavia and optimize the diagnosis of breast cancer
Stockholm July 6, 2020. NeoDynamics AB (Spotlight Stock Market: NEOD), today announced that the Company has initiated a collaboration with leading breast cancer clinics in Germany, which will act as reference centres supporting the introduction of the new pulse biopsy system NeoNavia, paving the way for a successful market introduction in Europe.NeoDynamics introduces pioneering pulse biopsy technology for ultrasound-guided minimally invasive biopsy in breast and axilla. Today the Company announced a collaboration with leading breast cancer clinics to support the successful introduction of